The British Journal of Psychiatry · 1993 · 15 citations · 6 references
MedicineNeurologyPharmacotherapyMovement DisordersNeurologic PharmacotherapyDrug-induced Movement DisordersMovement Disorder PharmacotherapyNeuromuscular Blocking AgentsNeuromuscular Disorder PharmacotherapyNeurophysiology Of Movement DisordersCalcium Channel PharmacologyDystonia PharmacotherapyDystonia TreatmentTardive Dyskinesia TreatmentTardive DystoniaVerapamil Therapy
A dramatic improvement in a patient with tardive dystonia was obtained with verapamil after the failure of other medicines. The use of verapamil or other calcium-channel blockers should be considered when treating drug-induced movement disorders.
6
J. A. Obeso, John C. Rothwell, A. E. Lang et al. · Neurology · 1983 · 147 citations
Medicine, Neurology, Neuroscience +10
Tardive Dyskinesia: Biological Mechanisms and Clinical Aspects
Fred Osview · Journal of Neuropsychiatry · 1989 · 44 citations
Medicine, Neurology, Pathobiology +10
Diltiazem-induced parkinsonism
Robbin S. Dick, S. Serge Barold · The American Journal of Medicine · 1989 · 43 citations
Calcium antagonists in the treatment of Tourette's disorder
Terri Walsh, B Lavenstein, William L. Licamele et al. · American Journal of Psychiatry · 1986 · 43 citations